CHICAGO, June 30 — For families facing a glioblastoma diagnosis, the timeline is brutally short. Median survival runs just 12 to 15 months after diagnosis, and the disease brings persistent headaches, seizures, memory loss, and progressive neurological decline. What this means for patients, and for the researchers trying to help them, is a race against a tumor that constantly adapts.
A new line of inquiry suggests these aggressive brain cancers may have a hidden vulnerability. Tumors appear to divert vitamin B3, also known as niacinamide, away from normal energy production and into a pathway that supports their own survival.
That altered pathway may drain key cellular resources, meaning cancer cells burn through materials they need to grow. The human side of this science is what drives it. Behind the breakthrough is the search for a way to disrupt that fuel supply.
A study published in Science Advances tested high-dose vitamin B3 therapy in patients. Early findings showed over 80% of patients had no disease progression at six months.
Researchers also observed stronger immune activity against tumors. This is early work, but it points toward a potential metabolic weakness that could be targeted. Glioblastoma is considered one of the most aggressive brain cancers.
It resists standard treatments, and little progress has been made in extending survival despite decades of research. Most patients receive surgery, chemotherapy, and radiation, along with steroids to control brain swelling. The drugs used to manage symptoms don’t act on the underlying metabolic changes that keep the tumor alive.
Supporting the body’s energy production and immune response through diet, lifestyle, and structured nutrient intake may help influence the same metabolic systems cancer depends on. That is not a treatment in itself, but it opens a door.
For families, this research offers a different way to think about what is happening inside the body. Instead of just attacking the tumor, scientists are exploring how to starve it by cutting off the nutrients it needs to rewire itself. The findings are preliminary.
But they suggest that the same vitamin B3 found in everyday foods might, at high doses, play a role in slowing one of the deadliest cancers known. What to watch next: larger trials testing whether this metabolic approach can extend survival beyond those 12 to 15 months.
For now, the science is asking a new question — not just how to kill cancer, but how to take away its fuel. Consult your doctor for medical advice.
